Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
-
Valérie Pennemans
, Jean-Michel Rigo
Abstract
Background: Recently, a lot of research has focused on the discovery of novel renal biomarkers. Among others, the urinary kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) have been proven to be promising biomarkers in a wide variety of renal pathologies. However, little is known about the normal concentrations in urine of healthy subjects. Therefore, the goal of our study is to establish reference values for urinary KIM-1, NGAL, N-acetyl-β-D-glucosamidase (NAG), and cystatin C in a healthy population, taking into account possible effects of age and gender.
Methods: We collected urine samples from 338 healthy, nonsmoking subjects between 0 and 95 years old. Subjects with elevated α1-microglobulin values were excluded. Next to the urinary concentrations of KIM-1, NGAL, NAG, and cystatin C, we measured urinary creatinine and specific gravity to correct for urinary dilution. The possible effect of age and gender on the four urinary biomarkers was investigated, and the reference values were established.
Results: For the absolute urinary concentrations of the biomarkers, age had a significant effect on all the biomarkers, except for cystatin C, whereas gender significantly affected all four of them, except for NAG. The normalization of biomarkers for creatinine and specific gravity had an effect on the correlation between the biomarkers on one hand and age and gender on the other.
Conclusions: In conclusion, age and gender had different effects on KIM-1, NGAL, NAG, and cystatin C. Based on this knowledge, age- and gender-specific reference values for KIM-1, NGAL, NAG, and cystatin C were established.
Conflict of interest statement
Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
References
1. Parikh C, Devarajan P. New biomarkers of acute kidney injury. Crit Care Med 2008;36:S159–65.10.1097/CCM.0b013e318168c652Search in Google Scholar
2. Tomlanovich S, Gelbetz H, Perlroth M, Stinson E, Myers B. Limitations of creatinine in quatifying the severity of cyclosporine-induced chronic nephropathy. Am J Kidney Dis 1986;8:332–7.10.1016/S0272-6386(86)80107-XSearch in Google Scholar
3. Ichimura T, Bonventre J, Bailly V, Wei H, Hession C, Cate R, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 1998;273:4135–42.10.1074/jbc.273.7.4135Search in Google Scholar
4. Huang Y, Don-Wauchope A. The clinical utility of kidney injury molecule 1 in the prediction, diagnosis and prognosis of acute kidney injury: a systematic review. Inflamm Allergy Drug Targets 2011;10:260–71.10.2174/187152811796117735Search in Google Scholar
5. Waanders F, van Timmeren MM, Stegeman CA, Bakker SJ, van Goor H. Kidney injury molecule-1 in renal disease. J Pathol 2010;220:7–16.10.1002/path.2642Search in Google Scholar
6. Prozialeck WC, Edwards JR, Lamar PC, Liu J, Vaidya VS, Bonventre JV. Expression of kidney injury molecule-1 (Kim-1) in relation to necrosis and apoptosis during the early stages of Cd-induced proximal tubule injury. Toxicol Appl Pharmacol 2009;238:306–14.10.1016/j.taap.2009.01.016Search in Google Scholar
7. Pennemans V, De Winter LM, Munters E, Nawrot TS, Van Kerkhove E, Rigo JM, et al. The association between urinary kidney injury molecule 1 and urinary cadmium in elderly during long-term, low-dose cadmium exposure: a pilot study. Environ Health 2011;10:77–9.10.1186/1476-069X-10-77Search in Google Scholar
8. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002;62:237–44.10.1046/j.1523-1755.2002.00433.xSearch in Google Scholar
9. Kjeldsen L, Johnsen AH, Sengeløv H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993;268: 10425–32.10.1016/S0021-9258(18)82217-7Search in Google Scholar
10. Gagneux-Brunon A, Delanaye P, Legrand D, Cavalier E, Mariat C. NGAL, biomarker of acute kidney injury in 2012. Nephrol Ther 2012;8:508–15.10.1016/j.nephro.2012.03.006Search in Google Scholar PubMed
11. Paragas N, Qiu A, Zhang Q, Samstein B, Deng SX, Schmidt-Ott KM, et al. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med 2011;17:216–22.10.1038/nm.2290Search in Google Scholar
12. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365:1231–8.10.1016/S0140-6736(05)74811-XSearch in Google Scholar
13. Makris K, Markou N, Evodia E, Dimopoulou E, Drakopoulos I, Ntetsika K, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med 2009;47:79–82.10.1515/CCLM.2009.004Search in Google Scholar PubMed
14. Tuladhar SM, Püntmann VO, Soni M, Punjabi PP, Bogle RG. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. J Cardiovasc Pharmacol 2009;53: 261–6.10.1097/FJC.0b013e31819d6139Search in Google Scholar PubMed
15. Bennett M, Dent CL, Ma Q, Dastrala S, Grenier F, Workman R, et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008;3:665–73.10.2215/CJN.04010907Search in Google Scholar PubMed PubMed Central
16. Chakraborty S, Kaur S, Guha S, Batra SK. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim Biophys Acta 2012;1826: 129–69.10.1016/j.bbcan.2012.03.008Search in Google Scholar PubMed PubMed Central
17. Clerico A, Galli C, Fortunato A, Ronco C. Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences. Clin Chem Lab Med 2012;50:1505–17.10.1515/cclm-2011-0814Search in Google Scholar PubMed
18. Cullen MR, Murray PT, Fitzgibbon MC. Establishment of a reference interval for urinary neutrophil gelatinase-associated lipocalin. Ann Clin Biochem 2012;49:190–3.10.1258/acb.2011.011105Search in Google Scholar PubMed
19. Cangemi G, Storti S, Cantinotti M, Fortunato A, Emdin M, Bruschettini M, et al. Reference values for urinary neutrophil gelatinase-associated lipocalin (NGAL) in pediatric age measured with a fully automated chemiluminescent platform. Clin Chem Lab Med 2012;23:1–5.Search in Google Scholar
20. Pennemans V, De Winter LM, Faes C, Van Kerkhove E, Reynders C, Rigo JM, et al. Effect of pH on the stability of kidney injury molecule 1 (KIM-1) and on the accuracy of its measurement in human urine. Clin Chim Acta 2010;411:2083–6.10.1016/j.cca.2010.09.008Search in Google Scholar PubMed
21. Weinstein JR, Anderson S. The aging kidney: physiological changes. Adv Chronic Kidney Dis 2010;17:302–7.10.1053/j.ackd.2010.05.002Search in Google Scholar PubMed PubMed Central
22. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 2005;113:192–200.10.1289/ehp.7337Search in Google Scholar PubMed PubMed Central
23. Mage DT, Allen RH, Gondy G, Smith W, Barr DB, Needham LL. Estimating pesticide dose from urinary pesticide concentration data by creatinine correction in the Third National Health and Nutrition Examination Survey (NHANES-III). J Expo Anal Environ Epidemiol 2004;14:457–65.10.1038/sj.jea.7500343Search in Google Scholar PubMed
24. Goldstein SL. Urinary kidney injury biomarkers and urine creatinine normalization: a false premise or not? Kidney Int 2010;78:433–5.10.1038/ki.2010.200Search in Google Scholar PubMed
25. Sarafidis K, Tsepkentzi E, Agakidou E, Diamanti E, Taparkou A, Soubasi V, et al. Serum and urine acute kidney injury biomarkers in asphyxiated neonates. Pediatr Nephrol 2012;27:1575–82.10.1007/s00467-012-2162-4Search in Google Scholar PubMed
26. Kim SS, Song SH, Kim IJ, Yang JY, Lee JG, Kwak IS, et al. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients. Diabetes Res Clin Pract 2012;97:251–7.10.1016/j.diabres.2012.02.019Search in Google Scholar PubMed
27. Krawczeski CD, Goldstein SL, Woo JG, Wang Y, Piyaphanee N, Ma Q, et al. Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass. J Am Coll Cardiol 2011;58:2301–9.10.1016/j.jacc.2011.08.017Search in Google Scholar PubMed PubMed Central
28. Askenazi DJ, Koralkar R, Levitan EB, Goldstein SL, Devarajan P, Khandrika S, et al. Baseline values of candidate urine acute kidney injury biomarkers vary by gestational age in premature infants. Pediatr Res 2011;70:302–6.10.1203/PDR.0b013e3182275164Search in Google Scholar PubMed PubMed Central
29. Huynh TK, Bateman DA, Parravicini E, Lorenz JM, Nemerofsky SL, Sise ME, et al. Reference values of urinary neutrophil gelatinase-associated lipocalin in very low birth weight infants. Pediatr Res 2009;66:528–32.10.1203/PDR.0b013e3181baa3ddSearch in Google Scholar PubMed PubMed Central
30. Nejat M, Hill JW, Edelstein CL, Devarajan P, Endre ZH. Albuminuria increases cystatin C excretion: implications for urinary biomakers. Nephrol Dial Transplant 2012;27:iii96–103.10.1093/ndt/gfr222Search in Google Scholar PubMed
©2013 by Walter de Gruyter Berlin Boston
Articles in the same Issue
- Masthead
- Masthead
- Editorials
- What is a biomarker? It’s time for a renewed definition
- Biomarker research and leading causes of death worldwide: a rather feeble relationship
- Thiosulfate in urine: new hope or new failure of a biomarker for prostate cancer?
- Review
- Acute coronary syndrome – the present and future role of biomarkers1)
- Mini Review
- Advance in molecular diagnostic tools for hepatitis B virus detection
- Opinion Paper
- Standardization and analytical goals for glycated hemoglobin measurement
- Guidelines and Recommendations
- Proposal for the use in emergency departments of cardiac troponins measured with the latest generation methods in patients with suspected acute coronary syndrome without persistent ST-segment elevation
- General Clinical Chemistry and Laboratory Medicine
- Current status of verification practices in clinical biochemistry in Spain
- Two site evaluation of the performance of a new generation point-of-care glucose meter for use in a neonatal intensive care unit
- Trp64Arg (rs4994) polymorphism of β3-adrenergic receptor gene is associated with hyperuricemia in a Chinese male population
- Quantification of vancomycin in human serum by LC-MS/MS
- Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation
- Autocorrelation and cross-correlation between hCGβ and PAPP-A in repeated sampling during first trimester of pregnancy
- Platelet oxidative stress and systemic inflammation in chronic spontaneous urticaria
- Reference Values
- Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
- Risks of mortality associated with common laboratory tests: a novel, simple and meaningful way to set decision limits from data available in the Electronic Medical Record
- Cancer Diagnostics
- Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis
- Thiosulfate in urine as a facilitator in the diagnosis of prostate cancer for patients with prostate-specific antigen less or equal 10 ng/mL
- Anemia and iron biomarkers in patients with early breast cancer. Diagnostic value of hepcidin and soluble transferrin receptor quantification1)
- Sensitive detection of EML4-ALK fusion oncoprotein of lung cancer by in situ proximity ligation assay
- Re-evaluation of laboratory predictors of response to current anemia treatment regimens of erythropoiesis stimulating agents in cancer patients
- Cardiovascular Diseases
- Evaluation of four sensitive troponin assays for risk assessment in acute coronary syndromes using a new clinically oriented approach for comparison of assays
- A combined index of cardiac biomarkers as a risk factor for early cardiovascular mortality in hemodialysis patients
- Prognostic utility of biochemical markers of cardiovascular risk: impact of biological variability
- Letters to the Editors
- Exploring the relationship between serum biomarkers, acute intracerebral changes and outcome after severe traumatic brain injury (TBI)
- Laboratory false-positive results: a clinician responsibility or a shared responsibility with requesting clinicians?
- The one hour lactose tolerance test
- High concentration of IgM-κ paraprotein causes over-estimation of serum total protein by certain biuret method
- Determining calculated free testosterone reference intervals in a normal adult male population
- Alveolar neopterin, procalcitonin, and IL-6 in relation to serum levels and severity of lung injury in ARDS
- Falsely elevated cobalamin concentration in multiple assays in a patient with pernicious anemia: a case study
- Leading Figures in Laboratory Medicine
- Research forever – Klaus Jung
Articles in the same Issue
- Masthead
- Masthead
- Editorials
- What is a biomarker? It’s time for a renewed definition
- Biomarker research and leading causes of death worldwide: a rather feeble relationship
- Thiosulfate in urine: new hope or new failure of a biomarker for prostate cancer?
- Review
- Acute coronary syndrome – the present and future role of biomarkers1)
- Mini Review
- Advance in molecular diagnostic tools for hepatitis B virus detection
- Opinion Paper
- Standardization and analytical goals for glycated hemoglobin measurement
- Guidelines and Recommendations
- Proposal for the use in emergency departments of cardiac troponins measured with the latest generation methods in patients with suspected acute coronary syndrome without persistent ST-segment elevation
- General Clinical Chemistry and Laboratory Medicine
- Current status of verification practices in clinical biochemistry in Spain
- Two site evaluation of the performance of a new generation point-of-care glucose meter for use in a neonatal intensive care unit
- Trp64Arg (rs4994) polymorphism of β3-adrenergic receptor gene is associated with hyperuricemia in a Chinese male population
- Quantification of vancomycin in human serum by LC-MS/MS
- Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation
- Autocorrelation and cross-correlation between hCGβ and PAPP-A in repeated sampling during first trimester of pregnancy
- Platelet oxidative stress and systemic inflammation in chronic spontaneous urticaria
- Reference Values
- Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
- Risks of mortality associated with common laboratory tests: a novel, simple and meaningful way to set decision limits from data available in the Electronic Medical Record
- Cancer Diagnostics
- Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis
- Thiosulfate in urine as a facilitator in the diagnosis of prostate cancer for patients with prostate-specific antigen less or equal 10 ng/mL
- Anemia and iron biomarkers in patients with early breast cancer. Diagnostic value of hepcidin and soluble transferrin receptor quantification1)
- Sensitive detection of EML4-ALK fusion oncoprotein of lung cancer by in situ proximity ligation assay
- Re-evaluation of laboratory predictors of response to current anemia treatment regimens of erythropoiesis stimulating agents in cancer patients
- Cardiovascular Diseases
- Evaluation of four sensitive troponin assays for risk assessment in acute coronary syndromes using a new clinically oriented approach for comparison of assays
- A combined index of cardiac biomarkers as a risk factor for early cardiovascular mortality in hemodialysis patients
- Prognostic utility of biochemical markers of cardiovascular risk: impact of biological variability
- Letters to the Editors
- Exploring the relationship between serum biomarkers, acute intracerebral changes and outcome after severe traumatic brain injury (TBI)
- Laboratory false-positive results: a clinician responsibility or a shared responsibility with requesting clinicians?
- The one hour lactose tolerance test
- High concentration of IgM-κ paraprotein causes over-estimation of serum total protein by certain biuret method
- Determining calculated free testosterone reference intervals in a normal adult male population
- Alveolar neopterin, procalcitonin, and IL-6 in relation to serum levels and severity of lung injury in ARDS
- Falsely elevated cobalamin concentration in multiple assays in a patient with pernicious anemia: a case study
- Leading Figures in Laboratory Medicine
- Research forever – Klaus Jung